Navigation Links
New study quantifies total costs of fragility fractures in 6 major European countries
Date:3/24/2011

Research presented today at the European Congress on Osteoporosis & Osteoarthritis by investigators from the UK and Sweden estimates that the economic burden of fragility fractures in five major European countries totals 31 billion Euro, with Germany bearing the highest costs. A majority of the economic burden is shown to be related to the costs incurred during the 1st year after the fracture, while pharmacological prevention and treatment management constitutes only a marginal share of the total economic cost.

Hip fractures contributed 56% to the overall costs, vertebral fractures 5%, wrist fractures 2% and a combined group of "other" fractures represented 37% of the total. Costs in Germany totaled 9.37 billion Euro, followed by Italy at 6.7 and the UK at 5.8 billion Euro.

The total annual economic burden of all fragility fractures in the six countries studied was found to be 31 billion Euro.

IOF President John Kanis, co-author of the study, stated, "Fragility fractures due to osteoporosis cause pain and disability, often having a severe impact on the quality of life of millions of Europeans. This important study reveals the enormous economic cost of fragility fractures. Prevention of fractures through early risk assessment and identification of those in need of treatment is the key to reducing the costs to national health care systems throughout Europe."


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. Study finds remarkable diversity of lichen species in Florida state park
2. UC Riverside geneticists to study how plants adapt to a changing environment
3. Experimental radioprotective drug safe for lung cancer patients, says Pitt study
4. Evolutionary winners and losers revealed in collaborative study
5. Study finds that overweight people really are big-boned
6. Study indicates vitamin A plays key role in the human body
7. Study provides new tool to monitor coral reef vital signs
8. New study pinpoints why some microbial genes are more promiscuous than others
9. Bacterial wipes research study
10. MU researcher leads new $6.6 million study that could lead to better corn plants
11. A research study analyzes marine spill prevention policies in Spain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems is ... log work hours, for employers to make sure the right employees are actually signing ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: